February 15, 2017 @ 11:00 am – 12:00 pm America/Chicago Timezone
Patti Kritzberger

Presentation Slide Handout

Program Description:

According to the American Medical Association (AMA), over 36 million people in the United States live with uncontrolled high blood pressure.  During this webinar, representatives from the AMA will introduce attendees to Target: BP™, an initiative developed in partnership with the American Heart Association to support providers and care teams as they help patients control their blood pressure.



  • Describe the impact of uncontrolled Blood Pressure (BP) from a public health perspective and from a patient’s perspective
  • Review how the Target: BP™ initiative can help with your practice’s blood pressure improvement efforts
  • Identify evidence-based best practices that practice sites can use to improve BP control: the M.A.P. checklists


Intended Audience:

This event is intended for medical practices, practitioners and health services organizations.


Featured Presenters:

Vikas Bhala, MPH, MBA, is an Improvement Advisor for Improving Health Outcomes at the American Medical Association (AMA). In this capacity, he drives quality by sharing best practices, analyzing data and managing operations relating to the group’s blood pressure control and HTN improvement efforts. Mr. Bhala received his undergraduate degree from the University of Illinois at Chicago in Psychology and his Master of Public Health and Master of Business Administration from Benedictine University.

Linda Murakami, RN, BSN, MSHA, is a Senior Program Manager for Quality Improvement in the Department of Chronic Disease Prevention and Management at the American Medical Association. In this role, she provides leadership and technical expertise to primary care teams by conducting data-driven, quality-improvement coaching. She worked with the AMA team in the development of their evidence-based tools and resources for improving hypertension control. Ms. Murakami has a clinical background as a registered nurse with a focus on the medical/oncology patient population.